Brochures
Learn More About the Aptamarker Platform
The Aptamarker Platform represents a next-generation approach to biomarker discovery, offering unprecedented insight into molecular variation through a reproducible aptamer library and NGS analysis. Whether you’re a researcher, clinician, or biotech innovator, these brochures provide detailed insights into how the platform works, its key advantages, and real-world applications across multiple therapeutic areas.
Browse the documents below to dive deeper into the science, technology, and potential impact of the Aptamarker Platform.
Aptamarker Platform Brochure
Discover the Aptamarker Platform — a next-generation, NGS-based proteomic technology with unmatched depth. Unlike traditional approaches, this platform uses a reproducible library of 268 million aptamer sequences applied to every sample. As a result, it enables comprehensive profiling of proteins in their true biological forms. This includes isoforms, complexes, cleavage products, and post-translational modifications. Consequently, researchers can measure all forms of all proteins from a single sample. The platform supports biomarker discovery, disease stratification, and personalized medicine with exceptional precision.
Cytokine Panel Brochure
Explore our Inflammation Panel, developed using the Aptamarker Platform, for advanced cytokine profiling. This panel targets 44 key cytokine proteins that play a central role in immune and inflammatory processes. Thanks to the platform’s depth and reproducibility, researchers can detect subtle variations in cytokine expression across diverse biological conditions. As a result, it is ideal for studies involving autoimmune diseases, chronic inflammation, or infectious diseases. Furthermore, the panel supports high-throughput analysis while maintaining accuracy and scalability.
The Aptamarker Platform – How it Works
Explore how the Aptamarker Platform is redefining biomarker discovery through next-generation proteomics, enabling high-resolution molecular profiling with unmatched scalability and precision. By leveraging a reproducible aptamer library and NGS readouts, the platform uncovers protein variants, conformational changes, and disease-relevant signatures that traditional approaches often miss.
Want the latest updates on our research and technology? Follow us on LinkedIn and stay connected.